{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:07:31Z","timestamp":1764238051969},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/bf02983235","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T16:57:26Z","timestamp":1225904246000},"page":"18-23","source":"Crossref","is-referenced-by-count":53,"title":["Leukemia and lymphoma of natural killer lineage cells"],"prefix":"10.1007","volume":"78","author":[{"given":"Kazuo","family":"Oshimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02983235_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","volume":"47","author":"G Trinchieri","year":"1989","unstructured":"Trinchieri G. Biology of natural killer cells.Adv Immunol. 1989;47: 187\u2013376.","journal-title":"Adv Immunol."},{"key":"BF02983235_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0167-5699(88)91317-5","volume":"9","author":"T Hercend","year":"1988","unstructured":"Hercend T, Schmidt RE. Characteristics and uses of natural killer cells.Immunol Today. 1988;9:291\u2013293.","journal-title":"Immunol Today."},{"key":"BF02983235_CR3","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","volume":"76","author":"MJ Robertson","year":"1990","unstructured":"Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells.Blood. 1990;76:2421\u20132438.","journal-title":"Blood."},{"key":"BF02983235_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0925-5710(96)00450-1","volume":"63","author":"K Oshimi","year":"1996","unstructured":"Oshimi K. Lymphoproliferative disorders of natural killer cells.Int J Hematol. 1996;63:279\u2013290.","journal-title":"Int J Hematol."},{"key":"BF02983235_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/0167-5699(92)90087-N","volume":"13","author":"LL Lanier","year":"1992","unstructured":"Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells.Immunol Today. 1992;13:392\u2013395.","journal-title":"Immunol Today"},{"key":"BF02983235_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.180.2.569","volume":"180","author":"MJ Sanchez","year":"1994","unstructured":"Sanchez MJ, Muench MO, Roncarolo MG, Roncarlo MG, Lanier LL, Phillips JH. Identification of a common T\/natural killer cell progenitor in human fetal thymus.J Exp Med. 1994; 180:569\u2013576.","journal-title":"J Exp Med."},{"key":"BF02983235_CR7","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood.V85.10.2654.bloodjournal85102654","volume":"85","author":"H Spits","year":"1995","unstructured":"Spits H, Lanier LL, Phillips JH. Development of human T and natural killer cells.Blood. 1995;85:2654\u20132670.","journal-title":"Blood."},{"key":"BF02983235_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.1998.tb01231.x","volume":"165","author":"H Spits","year":"1998","unstructured":"Spits H, Blom B, Jaleco A-C, et al. Early stages in the development of human T, natural killer and thymic dendritic cells.Immunol Rev. 1998;165:75\u201386.","journal-title":"Immunol Rev."},{"key":"BF02983235_CR9","first-page":"87","volume":"40","author":"K Oshimi","year":"2000","unstructured":"Oshimi K. Provisional classification and diagnostic criteria of NKcell tumors proposed by the NK-Cell Tumor Study Group [in Japanese].Ketsueki-Schuyou-ka. 2000;40:87\u201388.","journal-title":"Ketsueki-Schuyou-ka."},{"key":"BF02983235_CR10","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V90.6.2417","volume":"90","author":"R Suzuki","year":"1997","unstructured":"Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid\/ natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.Blood. 1997;90:2417\u20132428.","journal-title":"Blood."},{"key":"BF02983235_CR11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0145-2126(98)00194-5","volume":"23","author":"R Suzuki","year":"1999","unstructured":"Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid\/NK cell precursor acute leukemia and blastic NK cell lymphoma\/leukemia.Leuk Res. 1999;23:615\u2013624.","journal-title":"Leuk Res."},{"key":"BF02983235_CR12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF02986617","volume":"77","author":"R Suzuki","year":"2003","unstructured":"Suzuki R, Murata M, Kami M, et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.Int J Hematol. 2003;77:482\u2013489.","journal-title":"Int J Hematol."},{"key":"BF02983235_CR13","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V89.12.4665","volume":"89","author":"F Nakamura","year":"1997","unstructured":"Nakamura F, Tatsumi E, Kawano S, et al. Acute lymphoblastic leukemia\/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm.Blood. 1997;89: 4665\u20134666.","journal-title":"Blood."},{"key":"BF02983235_CR14","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","volume":"97","author":"L Chaperot","year":"2001","unstructured":"Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells.Blood. 2001;97: 3210\u20133217.","journal-title":"Blood."},{"key":"BF02983235_CR15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","volume":"99","author":"J Feuillard","year":"2002","unstructured":"Feuillard J, Jacob M-C, Valensi F, et al. Clinical and biologic features of CD4+CD56+ malignancies.Blood. 2002;99:1556\u20131563.","journal-title":"Blood."},{"key":"BF02983235_CR16","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","volume":"99","author":"D Leroux","year":"2002","unstructured":"Leroux D, Mugneret F, Callanan M, et al. CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique.Blood. 2002;99:4154\u20134159.","journal-title":"Blood."},{"key":"BF02983235_CR17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00000478-200207000-00003","volume":"26","author":"T Petrella","year":"2002","unstructured":"Petrella T, Comeau MR, Maynadie M, et al. \u201cAgranular CD4+ CD56+ hematodermic neoplasm\u201d (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.Am J Surg Pathol. 2002;26:852\u2013862.","journal-title":"Am J Surg Pathol."},{"key":"BF02983235_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","volume":"75","author":"N Imamura","year":"1990","unstructured":"Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukemia\/lymphoma: report of four cases and review of the literature: possible existence of a new clinical entity originating from the third lineage of lymphoid cells.Br J Haematol. 1990;75: 49\u201359.","journal-title":"Br J Haematol."},{"key":"BF02983235_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2141.2001.03038.x","volume":"115","author":"KL Mori","year":"2001","unstructured":"Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis.Br J Haematol. 2001;115:225\u2013228.","journal-title":"Br J Haematol."},{"key":"BF02983235_CR20","first-page":"782","volume":"7","author":"K,Yamada O Oshimi","year":"1993","unstructured":"Oshimi K,Yamada O, Kaneko T, et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders.Leukemia. 1993;7:782\u2013788.","journal-title":"Leukemia."},{"key":"BF02983235_CR21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V81.5.1342.1342","volume":"81","author":"T Yamamoto","year":"1993","unstructured":"Yamamoto T, Iwasaki T,Watanabe N, et al. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders.Blood. 1993;81:1342\u20131346.","journal-title":"Blood."},{"key":"BF02983235_CR22","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","volume":"76","author":"M Yamaguchi","year":"1995","unstructured":"Yamaguchi M, Kita K, Miwa H, et al. Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells.Cancer. 1995;76:2351\u20132356.","journal-title":"Cancer."},{"key":"BF02983235_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","volume":"93","author":"M Egashira","year":"1999","unstructured":"Egashira M, Kawamata N, Sugimoto K, Kaneko T, Oshimi K. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.Blood. 1999;93:599\u2013606.","journal-title":"Blood."},{"key":"BF02983235_CR24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2141.2001.02885.x","volume":"114","author":"C Wang","year":"2001","unstructured":"Trambas C,Wang Z, Cianfriglia M,Woods G. Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein.Br J Haematol. 2001;114:177\u2013184.","journal-title":"Br J Haematol."},{"key":"BF02983235_CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10428199909050949","volume":"34","author":"KF Wong","year":"1999","unstructured":"Wong KF, Zhang YM, Chan JKC. Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia: is there a consistent pattern?Leuk Lymphoma. 1999;34:241\u2013250.","journal-title":"Leuk Lymphoma."},{"key":"BF02983235_CR26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","volume":"155","author":"LLP,Wong K-F Siu","year":"1999","unstructured":"Siu LLP,Wong K-F, Chan JKC, Kwong YL. Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia: recognition of consistent patterns of genetic alterations.Am J Pathol. 1999;155:1419\u20131425.","journal-title":"Am J Pathol."},{"key":"BF02983235_CR27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","volume":"157","author":"LLP Siu","year":"2000","unstructured":"Siu LLP, Chan V, Chan JKC,Wong KF, Liang R, Kwong YL. Consistent patterns of allelic loss in natural killer cell lymphoma.Am J Pathol. 2000;157:1803\u20131809.","journal-title":"Am J Pathol."},{"key":"BF02983235_CR28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0145-2126(02)00065-6","volume":"26","author":"KF Wong","year":"2002","unstructured":"Wong KF. Genetic changes in natural killer cell neoplasms.Leuk Res. 2002;26:977\u2013978.","journal-title":"Leuk Res."},{"key":"BF02983235_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/labinvest.3780055","volume":"80","author":"T Li","year":"2000","unstructured":"Li T, Hongyo T, Syaifudin M, et al. Mutations in the p53 gene in nasal NK\/T-cell lymphoma.Lab Invest. 2000;80:493\u2013499.","journal-title":"Lab Invest."},{"key":"BF02983235_CR30","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1349-7006.2001.tb01059.x","volume":"92","author":"S Sakajiri","year":"2001","unstructured":"Sakajiri S, Kawamata N, Egashira M, Mori K, Oshimi K. Molecular analysis of tumor suppressor genes,Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.Jpn J Cancer Res. 2001;92:1048\u20131056.","journal-title":"Jpn J Cancer Res."},{"key":"BF02983235_CR31","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1349-7006.2002.tb01234.x","volume":"93","author":"K Sugimoto","year":"2002","unstructured":"Sugimoto K, Kawamata N, Sakajiri S, Oshimi K. Molecular analysis of oncogenes,ras family genes (N-ras, K-ras, H-ras),myc family genes (c-myc, N-myc) andmdm2 in natural killer cell neoplasms.Jpn J Cancer Res. 2002;93:1270\u20131277.","journal-title":"Jpn J Cancer Res."},{"issue":"suppl 2","key":"BF02983235_CR32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF03165101","volume":"76","author":"K Oshimi","year":"2002","unstructured":"Oshimi K. NK cell lymphoma.Int J Hematol. 2002;76(suppl 2): 118\u2013121.","journal-title":"Int J Hematol."},{"key":"BF02983235_CR33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","volume":"87","author":"J-F Emile","year":"1996","unstructured":"Emile J-F, Boulland M-L, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.Blood. 1996;87:1466\u20131473.","journal-title":"Blood"},{"key":"BF02983235_CR34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiology.204.2.9240537","volume":"204","author":"N Shikama","year":"1997","unstructured":"Shikama N, Izuno I, Oguchi M, et al. Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.Radiology. 1997;204:467\u2013470.","journal-title":"Radiology."},{"key":"BF02983235_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","volume":"83","author":"Y-X Li","year":"1998","unstructured":"Li Y-X, Coucke PA, Li J-Y, et al. Primary non-Hodgkin\u2019s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the roles of radiotherapy and chemotherapy.Cancer. 1998;83:449\u2013456.","journal-title":"Cancer."},{"key":"BF02983235_CR36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WL, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment.J Clin Oncol. 2000;18:54\u201363.","journal-title":"J Clin Oncol."},{"key":"BF02983235_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3960\/jslrt.41.93","volume":"41","author":"M Yamaguchi","year":"2001","unstructured":"Yamaguchi M, Ogawa S, Nomoto Y, et al. Treatment outcome of nasal NK-cell lymphoma: a report of 12 consecutively-diagnosed cases and a review of the literature.J Clin Exp Hematopathol. 2001; 41:93\u201399.","journal-title":"J Clin Exp Hematopathol."},{"key":"BF02983235_CR38","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.1995.13.3.666","volume":"13","author":"R,Todd D Liang","year":"1995","unstructured":"Liang R,Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma.J Clin Oncol. 1995;13: 666\u2013670.","journal-title":"J Clin Oncol."},{"key":"BF02983235_CR39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MMC Cheung","year":"1998","unstructured":"Cheung MMC, Chan JKC, Lau WH, et al. Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.J Clin Oncol. 1998;16:70\u201377.","journal-title":"J Clin Oncol."},{"issue":"suppl 1","key":"BF02983235_CR40","first-page":"400a","volume":"92","author":"T Kitoh","year":"1998","unstructured":"Kitoh T, Sawada M, Shirahase K, et al. Asparagine synthetase protein expression in leukemia cells: application of L-asparaginase treatment for leukemia [abstract].Blood. 1998;92(suppl 1):400a.","journal-title":"Blood."},{"key":"BF02983235_CR41","first-page":"108","volume":"46","author":"SuzukiT KitohT","year":"2003","unstructured":"KitohT, SuzukiT, Nagafuji K, et al. Identification of L-asparaginasesensitive nasal natural killer\/natural killer-likeT-cell lymphoma: usefulness of immunostaining result for asparagine synthetase in lymphoma cells [in Japanese].Ketsueki-Schuyou-ka. 2003;46:108\u2013109.","journal-title":"Ketsueki-Schuyou-ka."},{"key":"BF02983235_CR42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02982090","volume":"74","author":"K Nagafuji","year":"2001","unstructured":"Nagafuji K, Fujisaki T, Arima F, Ohshima K. L-asparaginase induced durable remission of relapsed nasal NK\/T-cell lymphoma after autologous peripheral blood stem cell transplantation.Int J Hematol. 2001;74:447\u2013450.","journal-title":"Int J Hematol."},{"key":"BF02983235_CR43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1700606","volume":"19","author":"R Liang","year":"1997","unstructured":"Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T\/NK cell lymphoma.Bone Marrow Transplant. 1997;19:91\u201393.","journal-title":"Bone Marrow Transplant."},{"key":"BF02983235_CR44","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/10428190127500","volume":"42","author":"K Takenaka","year":"2001","unstructured":"Takenaka K, Shinagawa K, Maeda Y, et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal-type CD56+ natural killer cell lymphomas.Leuk Lymphoma. 2001;42:1297\u20131303.","journal-title":"Leuk Lymphoma."},{"key":"BF02983235_CR45","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.V84.8.2721.2721","volume":"84","author":"A Tefferi","year":"1994","unstructured":"Tefferi A, Li C-Y,Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Chronic natural killer cell lymphocytosis: a descriptive clinical study.Blood. 1994;84:2721\u20132725.","journal-title":"Blood."},{"key":"BF02983235_CR46","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V81.9.2363.2363","volume":"81","author":"R Nash","year":"1993","unstructured":"Nash R, McSweeney P, Zambello R, Semenzato G, Loughran TP Jr. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.Blood. 1993;81:2363\u20132368.","journal-title":"Blood."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02983235\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T22:26:53Z","timestamp":1589063213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02983235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["BF02983235"],"URL":"https:\/\/doi.org\/10.1007\/bf02983235","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}